Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

South Shore Neurology Associates, Inc, Patchogue

Local Institution - 204, Rostock

Thomas Jefferson University - Clinical Research Institute, Philadelphia

Vaught Neurological Services, PLLC, Crab Orchard

Lake Norman Neurology, Mooresville

Asheville Neurology Specialists PA, Asheville

Accel Research Sites - Brain and Spine Institute of Port Orange - ERN - PPDS, Port Orange

University of Florida Health, Gainesville

Neurostudies Inc, Port Charlotte

Hope Neurology MS Center, Knoxville

Velocity Clinical Research - Cleveland - ERN - PPDS, Cleveland

Local Institution - 105, Canton

Local Institution - 200, Bochum

Michigan State University MS Clinic, East Lansing

Medical College of Wisconsin, Milwaukee

Shapiro Center for MS at the Minneapolis Clinic of Neurology, Minneapolis

Sanford Health, Sioux Falls

Consultants In Neurology, Northbrook

University of Chicago Medicine, Chicago

Local Institution - 111, Kansas City

CPFCC Neurology Research Dept., Overland Park

Local Institution - 206, Mannheim

Neurology Associates PC, Lincoln

Neuromedical Clinic of Central LA, Alexandria

Central Texas Neurology Consultants PA, Round Rock

Colorado Springs Neurological Associates, Colorado Springs

Stanford University, Palo Alto

MultiCare Institute for Research and Innovation, Tacoma

Hartford Healthcare CT, Southington

Neurology Center of New England P.C., Foxborough

Jersey Shore MS Center, Neptune City

Holy Name Hospital, Teaneck

Local Institution - 201, Dresden